Autoantibodies targeting mGluR1 are responsible for a rare type of autoimmune encephalitis that predominantly manifests as subacute cerebellar ataxia, the presence of clinical symptoms along with the detection of antibodies in the cerebrospinal fluid (CSF) or serum confirms the diagnosis. Here, GRM1 is linked to autoimmune encephalitis.